A detailed history of Janiczek Wealth Management, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 6,589 shares of EXEL stock, worth $236,742. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,589
Previous 5,681 15.98%
Holding current value
$236,742
Previous $134,000 10.45%
% of portfolio
0.03%
Previous 0.03%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$20.34 - $23.73 $18,468 - $21,546
908 Added 15.98%
6,589 $148,000
Q1 2024

Apr 15, 2024

BUY
$20.17 - $23.93 $87,275 - $103,545
4,327 Added 319.57%
5,681 $134,000
Q4 2023

Jan 26, 2024

BUY
$19.25 - $24.13 $2,656 - $3,329
138 Added 11.35%
1,354 $32,000
Q3 2023

Oct 13, 2023

BUY
$19.04 - $22.74 $2,360 - $2,819
124 Added 11.36%
1,216 $26,000
Q2 2023

Jul 11, 2023

BUY
$18.17 - $20.48 $3,706 - $4,177
204 Added 22.97%
1,092 $20,000
Q1 2023

Apr 21, 2023

BUY
$16.3 - $19.41 $14,474 - $17,236
888 New
888 $17,000
Q2 2022

Aug 03, 2022

BUY
$17.44 - $23.16 $401 - $532
23 Added 6.04%
404 $8,000
Q1 2022

May 05, 2022

BUY
$17.03 - $22.67 $6,488 - $8,637
381 New
381 $9,000
Q4 2021

Feb 02, 2022

SELL
$15.84 - $21.88 $1,948 - $2,691
-123 Closed
0 $0
Q3 2021

Oct 19, 2021

BUY
$16.3 - $21.14 $2,004 - $2,600
123 New
123 $3,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.